You’ve probably seen NAD+ described as an “energy molecule.” That’s true — but it doesn’t really explain what makes it interesting.
Think of NAD+ as a tiny cellular shuttle.
When your body breaks down carbohydrates, fats and proteins, NAD+ can accept high-energy electrons and temporarily become NADH. NADH then carries those electrons into the mitochondria, where they help power the chain of reactions used to produce ATP — the usable energy currency of your cells.
Then NADH is converted back into NAD+, ready to do the job again.
So NAD+ isn’t energy itself. It helps move energy through the system.
But that’s only half the story.
Your cells also spend NAD+
Some enzymes don't simply recycle NAD+ — they actually consume it.
One example is a family of enzymes called PARPs, which use NAD+ during cellular responses to DNA damage.
Another is the sirtuin family of enzymes, which depend on NAD+ and participate in cellular signaling, metabolism and stress responses.
And an enzyme called CD38 also breaks down NAD+ as part of several biological processes.
This means your body is constantly doing two things at once:
recycling NAD+ for metabolism
and
using NAD+ for other cellular functions.
So where does NAD+ come from?
Your body can make NAD+ using building blocks related to vitamin B3, including nicotinamide, nicotinic acid and other precursors.
That means NAD+ isn't some exotic molecule invented by the supplement industry. It is already inside your cells, all day, every day.
And this is where the healthy-aging story becomes interesting.
Scientists are studying whether NAD+ metabolism changes as we get older and whether influencing these pathways could affect aspects of human health.
But there is an important distinction between interesting biology and proven longevity benefits.
Animal research has produced compelling findings, while human research is still developing. Even the popular claim that NAD+ simply “declines with age” is not as settled as wellness headlines often make it sound: a 2025 scientific review found that consistent evidence for age-related NAD+ decline in humans is limited, and a 2026 study found whole-blood NAD+ remained remarkably stable across age groups.
The interesting part isn't the hype.
It's that one small molecule sits at the intersection of energy metabolism, cellular signaling and DNA-repair biology.
And once you understand that, you understand why researchers keep studying NAD+.
Feel Better. Know Why.
